Stifel Nicolaus initiates coverage on Pharmasset (Nasdaq: VRUS) with a Buy. Price target $13.

Stifel analyst, Edward H ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE